Closing Evidence Gaps in Clinical Prevention (2022)

Chapter: Appendix C: Public Meeting Agendas

Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
Previous Chapter: Appendix B: Research Methods
Page 165 Cite
Suggested Citation: "Appendix C: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Closing Evidence Gaps in Clinical Prevention. Washington, DC: The National Academies Press. doi: 10.17226/26351.
Save
Cancel

C

Public Meeting Agendas

FIRST PUBLIC MEETING
December 15, 2020
Videoconference via Zoom

11:00 AM Welcome and Introductions
  • Tracy Lieu, M.D., M.P.H., Committee Chair; Director, Kaiser Permanente Northern California Division of Research
11:10 AM AHRQ Perspective on the Statement of Task
  • Arlene Bierman, M.D., M.S., Director, Center for Evidence and Practice Improvement, AHRQ
11:20 AM NIH Perspective on the Statement of Task
  • David Murray, Ph.D., Associate Director for Prevention and Director, Office of Disease Prevention, NIH
11:30 AM Discussion
12:00 PM The Role of the USPSTF in Identifying Evidence Gaps
  • Amanda Borsky, Dr.P.H., M.P.P., Program Manager, U.S. Preventive Services Task Force Program, AHRQ
Page 166 Cite
Suggested Citation: "Appendix C: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Closing Evidence Gaps in Clinical Prevention. Washington, DC: The National Academies Press. doi: 10.17226/26351.
Save
Cancel
  • Carol M. Mangione, M.D., M.S.P.H., FACP, Chief, Division of General Medicine and Health Services Research; Barbara A. Levey & Gerald S. Levey Professor of Medicine and Public Health, UCLA; USPSTF Vice-Chair
12:25 PM The Role of NIH in Addressing Evidence Gaps
  • Carrie Klabunde, Ph.D., Senior Advisor for Disease Prevention, Office of Disease Prevention, NIH
12:40 PM Discussion
1:00 PM Adjourn

SECOND PUBLIC MEETING
March 4, 2021
Videoconference via Zoom

11:00 AM Welcome and Introductions
  • Tracy Lieu, M.D., M.P.H., Committee Chair; Director, Kaiser Permanente Northern California Division of Research
11:10 AM Pathways to Addressing Evidence Gaps
  • Chyke A. Doubeni, M.D., M.P.H., Member, USPSTF; Director, Mayo Clinic Center for Health Equity and Community Engagement Research
  • Paul Doria-Rose, Ph.D., D.V.M., Chief, Healthcare Assessment Research Branch, Health Delivery Research Program, Division of Cancer Control and Population Sciences, NCI
  • Doug Corley, M.D., Ph.D., Lead Investigator, NCI PROSPR Consortium; Research Scientist, Kaiser Permanente Northern California Division of Research
11:40 AM Moderated Discussion
12:35 PM Break
12:40 PM Taxonomy: Categorizing Evidence Gaps in Order to Address Them
  • Alex H. Krist, M.D., M.P.H., Chair, USPSTF; Professor of Family Medicine and Population Health, Virginia Commonwealth University
Page 167 Cite
Suggested Citation: "Appendix C: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Closing Evidence Gaps in Clinical Prevention. Washington, DC: The National Academies Press. doi: 10.17226/26351.
Save
Cancel
  • Karen A. Robinson, Ph.D., M.Sc., Director, Evidence-Based Practice Center, Johns Hopkins University
  • Susan J. Curry, Ph.D., Senior Advisor for Preventive Services, NIH; Dean Emerita and Distinguished Professor of Health Management and Policy, University of Iowa
1:10 PM Moderated Discussion
2:00 PM Adjourn

THIRD PUBLIC MEETING
March 16, 2021
Videoconference via Zoom

11:00 AM Welcome and Introductions
  • Tracy Lieu, M.D., M.P.H., Committee Chair; Director, Kaiser Permanente Northern California Division of Research
11:10 AM Perspectives on Addressing Evidence Gaps: The CDC Community Guide
  • Amy Lansky, Ph.D., M.P.H., Director, CDC Community Guide
11:20 AM Perspectives on Addressing Evidence Gaps: Funders
  • Michael S. Lauer, M.D., Deputy Director for Extramural Research, NIH
  • Harold (Hal) Sox, M.D., Director, Peer Review, PCORI
  • David Atkins, M.D., M.P.H., Director of Health Services Research & Development, VA
11:50 AM Moderated Discussion
12:10 PM Break
12:15 PM Case Example: Autism Screening “I” Statement Impact on the Research Community
  • Michael Silverstein, M.D., M.P.H., Member, USPSTF; Professor of Pediatrics, Director of the Division of General Academic Pediatrics, and Vice Chair of Research for the Department of Pediatrics, Boston University School of Medicine
Page 168 Cite
Suggested Citation: "Appendix C: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Closing Evidence Gaps in Clinical Prevention. Washington, DC: The National Academies Press. doi: 10.17226/26351.
Save
Cancel
  • Ann E. Wagner, Ph.D., Department of Health and Human Services National Autism Coordinator, Office of NIMH Director, NIMH, NIH
  • Sarabeth Broder-Fingert, M.D., M.P.H., Associate Professor of Pediatrics, Boston University School of Medicine; Co-Director, Innovation in Autism Disparities, Inclusion, Outreach, and Transition Services Lab, Boston University
12:30 PM Moderated Discussion
1:05 PM Reflections on a Taxonomy of Evidence Gaps and Research to Close Them
  • Ned Calonge, M.D., M.P.H., President and Chief Executive Officer, Colorado Trust; Associate Professor of Family Medicine, Colorado School of Medicine, and Associate Professor of Epidemiology, Colorado School of Public Health, University of Colorado Denver
  • Alan I. Leshner, Ph.D., Chief Executive Officer Emeritus, AAAS, and Executive Publisher, Science Magazine; Former Director, NIDA; Former Deputy Director and Acting Director, NIMH
2:00 PM Adjourn

FOURTH PUBLIC MEETING
June 24, 2021
Videoconference via Zoom

11:30 AM Welcome
  • Tracy Lieu, M.D., M.P.H., Committee Chair; Director, Kaiser Permanente Northern California Division of Research
11:35 AM NIH Stories of Success in Disease Prevention: Informing National Recommendations about Clinical Preventive Services
  • Carrie Klabunde, Ph.D., Senior Advisor for Disease Prevention, Office of Disease Prevention, NIH
12:15 PM Adjourn
Page 165 Cite
Suggested Citation: "Appendix C: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Closing Evidence Gaps in Clinical Prevention. Washington, DC: The National Academies Press. doi: 10.17226/26351.
Save
Cancel
Page 165
Page 166 Cite
Suggested Citation: "Appendix C: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Closing Evidence Gaps in Clinical Prevention. Washington, DC: The National Academies Press. doi: 10.17226/26351.
Save
Cancel
Page 166
Page 167 Cite
Suggested Citation: "Appendix C: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Closing Evidence Gaps in Clinical Prevention. Washington, DC: The National Academies Press. doi: 10.17226/26351.
Save
Cancel
Page 167
Page 168 Cite
Suggested Citation: "Appendix C: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Closing Evidence Gaps in Clinical Prevention. Washington, DC: The National Academies Press. doi: 10.17226/26351.
Save
Cancel
Page 168
Next Chapter: Appendix D: Committee Member and Staff Biographies
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.